axoCells™ Human iPSC-Derived Atrial Cardiomyocytes, Media, Supplement and Coating kit, male donor, ≥1 million cells
axoCells Human iPSC-Derived Atrial Cardiomyocytes (=1 million cells), Cardiomyocyte Maintenance Media (500ml) and Fibronectin coating (100 µl) for cardiovascular research. Atrial cardiomyocytes made from iPSCs generated from a 74-year-old male donor's pulmonary fibroblasts.
Receive your quote directly from the manufacturer.
axoCells™ Human iPSC-Derived Atrial Cardiomyocytes, Media, Supplement and Coating kit containing axoCells Human iPSC-Derived Atrial Cardiomyocytes (≥1 million cells), Cardiomyocyte Maintenance Media (500ml), and Fibronectin coating (100 µl) for cardiovascular research. Atrial cardiomyocytes made from iPSCs generated from a 74-year-old male donor's pulmonary fibroblasts.
Key highlights include:
- Spontaneously beat 3 days post-thaw and assay-ready in just 7 days
- No evidence of endogenous arrhythmias
- Demonstrate functional response to atrial-specific compounds including carbachol
These cells are frequently used in in vitro cardiotoxicity models to assess drug safety models and to support testing of irregular and abnormally fast heart rates (including atrial fibrillation). They can also be used in co-culture with other cells (including ventricular cardiomyocytes).
